Hypertriglyceridemia
📧 Sign up to get email alerts when something new happens for Hypertriglyceridemia.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2014-01-10Clinical Trial Update: Efficacy Study of Diazoxide Choline to Treat Hypertriglyceridemia [Phase 2]
Phase 2 trial evaluating diazoxide choline for hypertriglyceridemia (a form of dyslipidemia) has completed.
-
CLINICAL_TRIALS trial_result · 2014-01-10Clinical Trial Update: Pharmacokinetic Study of Diazoxide Choline in Hypertriglyeridemic Subjects [Phase 1]
This clinical trial update reports a Phase 1 pharmacokinetic study of diazoxide choline in subjects with hypertriglyceridemia. The study spo…
-
CLINICAL_TRIALS trial_result · 2014-01-08Clinical Trial Update: Assess the Safety and Efficacy of NKPL66 (CaPre™) in the Treatment of Mild-to-high Hypertriglyceridemia [Phase 2]
Phase 2 trial assessing the safety and efficacy of CaPre (NKPL66) in mild-to-high hypertriglyceridemia has completed.
-
CLINICAL_TRIALS trial_result · 2014-01-06Clinical Trial Update: Epanova® Compared to Lovaza® In a Pharmacokinetic, Single-dose, Evaluation [Phase 2]
Phase 2 pharmacokinetic, single-dose study comparing Epanova to Lovaza in adults with severe hypertriglyceridemia. The trial assessed pharma…
-
EMA guidance · 2013-12-20Acipimox only to be used as additional or alternative treatment to reduce high triglyceride levels
The EMA announces that acipimox should be used only as an additional or alternative treatment to reduce high triglyceride levels, not as a f…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2013-12-10Clinical Trial Update: Effect of Maraviroc on Metabolic Function in Obese Subjects (Phase I) [Phase 1]
This ClinicalTrials.gov update reports the completion of a Phase I study assessing maraviroc's effect on metabolic function in obese subject…
-
FDA approval · 2013-12-04FDA Approved: FENOFIBRIC ACID — Original Application (Lupin Pharmaceuticals, Inc.)
The FDA approved Lupin Pharmaceuticals' original application for fenofibric acid, a lipid-lowering agent indicated for certain lipid disorde…
-
FDA approval · 2013-11-15FDA Approved: LOVAZA — Supplemental Application (Waylis Therapeutics LLC)
FDA approves a supplemental application for Lovaza (omega-3-acid ethyl esters) submitted by Waylis Therapeutics LLC.
-
EMA guidance · 2013-11-08PRAC recommends using acipimox only as additional or alternative treatment to lower high triglyceride levels
EU authorities recommend using acipimox only as an additional or alternative treatment to lower high triglyceride levels, not as a first-lin…
-
CLINICAL_TRIALS trial_result · 2013-10-28Clinical Trial Update: A Clinical Trial to Evaluate the Safety and Efficacy of ZYH7 Compared to Fenofibrate in Patients With Dyslipidemia [Phase 2]
A Phase 2 clinical trial comparing ZYH7 to fenofibrate in patients with hypertriglyceridemia and dyslipidemia has completed.
-
CLINICAL_TRIALS trial_result · 2013-10-22Clinical Trial Update: Effects of Prescription Omega-3 Acids on Glucose and Lipoprotein Lipids in Subjects With Hypertriglyceridemia [NA]
A completed clinical trial evaluating the effects of prescription omega-3 fatty acids on glucose and lipoprotein lipids in subjects with hyp…
-
FDA approval · 2013-10-18FDA Approved: FENOFIBRATE — Supplemental Application (Lupin Pharmaceuticals, Inc.)
The FDA approved a supplemental application for Fenofibrate submitted by Lupin Pharmaceuticals, Inc. This indicates a change or addition to …
-
CLINICAL_TRIALS trial_result · 2013-09-23Clinical Trial Update: Fructose-Induced Palmitate Synthesis in Overweight Subjects [Phase 1]
A Phase 1 clinical trial evaluating fructose-induced palmitate synthesis in overweight adults has completed. The study population included i…
-
FDA approval · 2013-09-11FDA Approved: LOVAZA — Supplemental Application (Waylis Therapeutics LLC)
The FDA approved a supplemental application for Lovaza (omega-3-acid ethyl esters) submitted by Waylis Therapeutics LLC. This approval likel…
-
CLINICAL_TRIALS trial_result · 2013-09-06Clinical Trial Update: Epanova® for Lowering Very High Triglycerides [Phase 2, Phase 3]
Epanova was studied in phase 2 and phase 3 trials to lower very high triglycerides in patients with hypertriglyceridemia. The study is compl…
-
FDA approval · 2013-08-06FDA Approved: FENOFIBRATE — Supplemental Application (Rhodes Pharmaceuticals L.P.)
The FDA approved a supplemental application for fenofibrate from Rhodes Pharmaceuticals L.P., authorizing a new generic version of the drug.
-
FDA approval · 2013-07-26FDA Approved: FENOFIBRATE — Supplemental Application (Mylan Pharmaceuticals Inc.)
FDA approves a supplemental application for fenofibrate from Mylan Pharmaceuticals Inc., approving changes to the approved generic product.
-
FDA approval · 2013-07-26FDA Approved: FENOFIBRATE — Original Application (Apotex Corp.)
The FDA approves the original (ANDA) application for fenofibrate from Apotex Corp., granting generic approval for the lipid-lowering medicin…
-
CLINICAL_TRIALS research · 2013-07-25Clinical Trial Update: Bioavailability of EPA and DHA From Two Dietary Supplements [NA]
This clinical trial update reports on the bioavailability of EPA and DHA from two dietary supplements in adults with hypertriglyceridemia.
-
FDA approval · 2013-06-26FDA Approved: LOVAZA — Supplemental Application (Waylis Therapeutics LLC)
The FDA approved a supplemental application for Lovaza (omega-3-acid ethyl esters) submitted by Waylis Therapeutics LLC.
-
CLINICAL_TRIALS trial_result · 2013-05-29Clinical Trial Update: Trial of Lovaza in Adolescents With Mild to Moderately Elevated Triglycerides [Phase 2]
A Phase 2 trial evaluating Lovaza in adolescents with mild to moderately elevated triglycerides was terminated. Results from the study have …
-
CLINICAL_TRIALS withdrawal · 2013-03-22Clinical Trial Update: Garlic in Hyperlipidemia Caused by HAART [Phase 2]
This update indicates a Phase 2 trial evaluating garlic for HAART-induced hyperlipidemia in people with HIV has been withdrawn.
-
CLINICAL_TRIALS trial_result · 2013-02-28Clinical Trial Update: Combined Effects of Bioactive Compounds in Lipid Profile [Phase 2, Phase 3]
A Phase 2/3 clinical trial evaluating the combined effects of bioactive compounds on lipid levels in individuals with hyperlipidemia and ele…
-
CLINICAL_TRIALS trial_result · 2013-02-25Clinical Trial Update: Lovaza Mechanisms of Action [Phase 4]
An update on a Phase 4 trial evaluating the mechanism of action of Lovaza (omega-3-acid ethyl esters) in adults with moderate hypertriglycer…
-
CLINICAL_TRIALS research · 2013-02-06Clinical Trial Update: Consumption of Whole Grains and Legumes Modulates the Genetic Effect of the APOA5 -1131C Variant [NA]
A completed clinical trial from Yonsei University evaluated whether consuming whole grains and legumes modulates the effect of the APOA5 -11…